Osteoporosis medication
Intervention1 paper4 findings
- Humans1
Outcomes
2Walking ability
no changein humans1Low certainty
1 study
Walking ability
no changein humans1Low certainty
Osteoporosis medication has no effect on walking ability in humans (aOR 1.03, 95% CI 0.98–1.09).
Humansat 7 days postoperatively
Impact of Osteoporosis Therapy in Geriatric Proximal Femur Fractures: A Retrospective Analysis from the German Registry for Geriatric Trauma (ATR-DGU®) · Journal of clinical medicine · 7 Sep 2026
Mortality
no changein humans1Low certainty
1 study
Mortality
no changein humans1Low certainty
Osteoporosis medication has no effect on mortality in humans (aOR 0.93, 95% CI 0.86–1.01).
Humansduring acute hospital stay
Impact of Osteoporosis Therapy in Geriatric Proximal Femur Fractures: A Retrospective Analysis from the German Registry for Geriatric Trauma (ATR-DGU®) · Journal of clinical medicine · 7 Sep 2026
Associations
2Mortality
upin humans1Low certainty
1 study
Mortality
upin humans1Low certainty
Osteoporosis medication raises the risk of mortality in humans (aOR 1.12, 95% CI 1.01–1.25).
Humansat 120-day follow-up120 daysn = 19,544
Impact of Osteoporosis Therapy in Geriatric Proximal Femur Fractures: A Retrospective Analysis from the German Registry for Geriatric Trauma (ATR-DGU®) · Journal of clinical medicine · 7 Sep 2026
Trochanteric fracture
upin humans1Low certainty
1 study
Trochanteric fracture
upin humans1Low certainty
Osteoporosis medication raises the risk of trochanteric fracture in humans (aOR 1.19, 95% CI 1.15–1.24).
Humansin patients with surgically treated proximal femur fractures
Impact of Osteoporosis Therapy in Geriatric Proximal Femur Fractures: A Retrospective Analysis from the German Registry for Geriatric Trauma (ATR-DGU®) · Journal of clinical medicine · 7 Sep 2026
Funding
National Institute on AgingUS$666.3k1 grant since 2023